Sign in
Not yet taking people in FrancePhase 1

Testing RUPISTAR in adults with advanced breast cancer that has an ESR1 mutation

Tests RUPISTAR in adults with advanced, hormone-sensitive breast cancer with an ESR1 mutation.

Key facts

Who runs it
Evexta Bio
Where
Lyon and Saint-Herblain Cedex, FranceSee the 2 sites
Registry title
RUPISTAR: A Study in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutation
Status
Not yet recruiting
Phase
Phase 1
People taking part
6 people, planned
Started
12 Nov 2026
Expected to end
5 Mar 2028
Type of study
Interventional
Record updated
9 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with ER-positive, HER2-negative breast cancer that has spread or cannot be removed, and who have an ESR1 mutation.

Age
18 years or older
Sex
All sexes can join
Disease stage
ER-positive, HER2-negative advanced or metastatic breast cancer
Biomarker or test result
An ESR1 mutation

Where in France

  • Centre Leon BerardLyon, FranceNot yet recruiting
  • Institut De Cancerologie De L OuestSaint-Herblain Cedex, FranceNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Testing RUPISTAR in adults with advanced breast cancer that has an ESR1 mutationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 10 November 2026.
Record updated
9 November 2026